Mesa Laboratories Inc.

NASDAQ: MLAB · Real-Time Price · USD
67.81
-1.47 (-2.12%)
At close: Aug 14, 2025, 3:59 PM
67.89
0.12%
After-hours: Aug 14, 2025, 04:20 PM EDT

Mesa Laboratories Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
240.98M 216.19M 219.08M 184.34M 133.94M
Cost of Revenue
90.11M 82.94M 85.39M 75.25M 46.92M
Gross Profit
150.87M 133.25M 133.69M 109.09M 87.01M
Operating Income
16.34M -272.07M -30.5M -20.37M -5.3M
Interest Income
n/a n/a n/a n/a 107K
Pretax Income
5.96M -275.65M -389K 3.57M 2.3M
Net Income
-1.97M -254.25M 930K 1.87M 3.27M
Selling & General & Admin
115.02M 111.49M 109.88M 88.62M 64.18M
Research & Development
19.52M 19.3M 20.49M 15.77M 10.39M
Other Expenses
n/a 274.53M n/a n/a 91K
Operating Expenses
134.53M 406.55M 130.37M 104.39M 74.66M
Interest Expense
11.86M 5.7M 4.77M 3.88M 8.02M
Selling & Marketing Expenses
41.68M 38.63M 37.44M 28.31M 18.48M
Cost & Expenses
224.64M 488.26M 215.76M 179.63M 121.58M
Income Tax Expense
7.93M -21.4M -1.32M 1.7M -971K
Shares Outstanding (Basic)
5.43M 5.39M 5.32M 5.21M 4.97M
Shares Outstanding (Diluted)
5.43M 5.39M 5.36M 5.33M 5.12M
EPS (Basic)
-0.36 -47.2 0.17 0.36 0.66
EPS (Diluted)
-0.36 -47.2 0.17 0.35 0.64
EBITDA
42.35M -238.38M 36.45M 29.77M 12.36M
EBIT
17.82M -269.95M 3.32M 4.7M 10.33M
Depreciation & Amortization
24.53M 31.57M 33.13M 25.07M 17.47M